James Brorson to Treatment Outcome
This is a "connection" page, showing publications James Brorson has written about Treatment Outcome.
Connection Strength
0.345
-
Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.
Score: 0.091
-
Neurologic complications of implantable devices. Handb Clin Neurol. 2021; 177:211-220.
Score: 0.068
-
Outcomes of Patients With Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation: A Multicenter Cohort Study. Neurology. 2025 Aug 12; 105(3):e213876.
Score: 0.023
-
Estimated Theoretical Benefit of Aggressive LDL Lowering in Patients With Symptomatic Intracranial Atherosclerosis. Neurology. 2025 Jul 08; 105(1):e213768.
Score: 0.023
-
Endovascular thrombectomy for distal medium vessel occlusions: A literature review. J Stroke Cerebrovasc Dis. 2025 Jan; 34(1):108134.
Score: 0.022
-
The Zoom RDL radial access system for neurointervention: An early single-center experience. J Neurointerv Surg. 2024 Feb 12; 16(3):266-271.
Score: 0.021
-
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomy. J Stroke Cerebrovasc Dis. 2023 Aug; 32(8):107227.
Score: 0.020
-
Real-World Outcomes for Basilar Artery Occlusion Thrombectomy With Mild Deficits: The National Inpatient Sample. Stroke. 2023 08; 54(8):2031-2039.
Score: 0.020
-
Ipsilateral Nonstenotic Carotid Disease in Minor Ischemic Stroke: an Exploratory Analysis of The POINT Randomized Clinical Trial. J Stroke Cerebrovasc Dis. 2020 Nov; 29(11):105115.
Score: 0.016
-
Mechanical Thrombectomy for Patients with In-Hospital Ischemic Stroke: A Case-Control Study. J Stroke Cerebrovasc Dis. 2020 May; 29(5):104692.
Score: 0.016
-
Clinical Characteristics and Emergent Therapeutic Interventions in Patients Evaluated through the In-hospital Stroke Alert Protocol. J Stroke Cerebrovasc Dis. 2019 May; 28(5):1362-1370.
Score: 0.015
-
Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv. 2003 Dec; 60(4):524-8.
Score: 0.005
-
Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events. Catheter Cardiovasc Interv. 2002 Feb; 55(2):189-94.
Score: 0.005